Picture [LSUS] – The Business Web Portal 650x65px
Document › Details

Concept Life Sciences Holdings Ltd.. (10/24/17). "Press Release: Concept Life Sciences Appoints Philip Payne as Chief Commercial Officer". Manchester.

Organisations Organisation Concept Life Sciences, Manchester
  Group Spectris (Group)
  Organisation 2 Aptuit Ltd.
  Group Evotec (Group)
Products Product drug discovery
  Product 2 drug development
Persons Person Payne, Philip (Concept Life Sciences 201710– CCO before Aptuit + Catalent + Reading Scientific Services)
  Person 2 Handley, John (Concept Life Sciences 201708– COO before Envigo + Harlan Laboratories + Safe Pharm Labs)

Appointment supports continued expansion of the group and completes leadership team

Concept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, today announced it has appointed Philip Payne as Chief Commercial Officer, to support the group’s continued growth. Philip completes Concept’s leadership team, following the appointment in August of John Handley as COO.

Philip will work with Concept’s executive team and board to drive the group’s commercial strategy, leading the business development function and helping to guide the next stage of the Company’s growth. He will be responsible for managing the sales team, including identification of new service areas, geographies and markets, supporting the broadening of Concept’s reach into Europe and the US.

Philip has 27 years’ experience in managing the integration of business development in an international environment, and has gained cross-sector expertise through roles in pharma and biotech discovery as well as analytical and development services. He joins Concept from Aptuit, where he held various roles, including Vice President of Sales, and was responsible for the global business development team and strategic accounts. Prior to joining Aptuit he was Business Development Director Europe and Asia for Sterile Technologies at Catalent Pharma Solutions, and Pharmaceutical Business Development Director with Reading Scientific Services Ltd.

Michael Fort, Executive Chairman, Concept Life Sciences, said: “Philip’s experience in managing multidisciplinary, international teams across a range of industries will be a great asset as Concept’s rapid rate of expansion continues. Following on from John’s appointment as COO, Concept now has an extremely strong leadership team. We are delighted to welcome Philip to the group.”

Philip Payne, Chief Commercial Officer, Concept Life Sciences, said: “I am excited to join Concept at this pivotal stage in the growth of the Company, and look forward to working with the team to meet the group’s commercial and strategic objectives.”


Photo: Philip Payne
For a high-resolution image please contact Zyme Communications

Media contact

Katie Odgaard
Zyme Communications
T: +44 (0)7787 502 947

About Concept Life Sciences

Concept Life Sciences provides integrated, high quality drug discovery, development and analytical services to the life science sector. Formed as a result of targeted acquisition and organic growth, the Company has the in-house expertise and resource to support customers with projects spanning from target discovery to the clinic, adding value and IP throughout the discovery pathway.

With a track record of delivering knowledge-based, science-led solutions, the Company employs over 700 FTEs, including more than 500 highly skilled, experienced scientists, supporting its global client base from 10 state of the art laboratory facilities.

Concept Life Sciences has worked with all of the top 10 pharma and biotech companies, and is targeting revenues exceeding $60m in 2017. Having experienced rapid growth, the Company remains focused on problem solving, quality, collaboration, and flexibility.

Concept Life Sciences was formed in 2014 with backing from private equity firm Equistone Partners Europe.

Record changed: 2017-11-03


Picture [LSUS] – The Business Web Portal 650x65px

More documents for Spectris (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUS] – The Business Web Portal 650x65px

» top